These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 21963513

  • 1. Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile.
    Filippatos TD, Tsimihodimos V, Derdemezis CS, Gazi IF, Saougos V, Mikhailidis DP, Tselepis AD, Elisaf MS.
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):330-6. PubMed ID: 21963513
    [Abstract] [Full Text] [Related]

  • 2. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S, Dostal E, Dukát A, Gavorník P, Kucera M, Gruber K.
    Neuro Endocrinol Lett; 2011 Apr; 32(4):502-9. PubMed ID: 21876506
    [Abstract] [Full Text] [Related]

  • 3. Serum hsCRP and visfatin are elevated and correlate to carotid arterial stiffness in spinal cord-injured subjects.
    La Favor JD, Hollis BC, Mokshagundam SL, Olive JL.
    Spinal Cord; 2011 Sep; 49(9):961-6. PubMed ID: 21625240
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients.
    Chen L, Liu W, Lai S, Li Y, Wang X, Zhang H.
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):935-41. PubMed ID: 23470357
    [Abstract] [Full Text] [Related]

  • 5. Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease.
    Mu J, Feng B, Ye Z, Yuan F, Zeng W, Luo Z, Qi W.
    J Nephrol; 2011 Aug; 24(2):177-84. PubMed ID: 20602330
    [Abstract] [Full Text] [Related]

  • 6. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
    Nüsken KD, Petrasch M, Rauh M, Stöhr W, Nüsken E, Schneider H, Dötsch J.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.
    Palaniappan LP, Kwan AC, Abbasi F, Lamendola C, McLaughlin TL, Reaven GM.
    Metabolism; 2007 Jul; 56(7):899-904. PubMed ID: 17570249
    [Abstract] [Full Text] [Related]

  • 8. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
    Wang P, Bai C, Xu QY, Xu TY, Su DF, Sassard J, Miao CY.
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
    [Abstract] [Full Text] [Related]

  • 9. Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers.
    Bo S, Ciccone G, Baldi I, Gambino R, Mandrile C, Durazzo M, Gentile L, Cassader M, Cavallo-Perin P, Pagano G.
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):423-30. PubMed ID: 19073361
    [Abstract] [Full Text] [Related]

  • 10. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ, Ma Xn, Hu XF, Kang SX, Chen SK, Cianflone K, Lu HL.
    J Pediatr Endocrinol Metab; 2013 Jul; 26(1-2):111-8. PubMed ID: 23327785
    [Abstract] [Full Text] [Related]

  • 11. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ, Olszanecka-Glinianowicz M, Kocełak P, Bożentowicz-Wikarek M, Brzozowska A, Mossakowska M, Puzianowska-Kuźnicka M, Grodzicki T, Więcek A, Chudek J.
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [Abstract] [Full Text] [Related]

  • 12. Atherogenic lipid profile in Behçet's disease: evidence of alteration of HDL subclasses.
    Messedi M, Jamoussi K, Frigui M, Laporte F, Turki M, Chaabouni K, Mnif E, Jaloulli M, Kaddour N, Bahloul Z, Ayedi F.
    Arch Med Res; 2011 Apr; 42(3):211-8. PubMed ID: 21722817
    [Abstract] [Full Text] [Related]

  • 13. Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke.
    Lu LF, Yang SS, Wang CP, Hung WC, Yu TH, Chiu CA, Chung FM, Shin SJ, Lee YJ.
    J Stroke Cerebrovasc Dis; 2009 Apr; 18(5):354-9. PubMed ID: 19717018
    [Abstract] [Full Text] [Related]

  • 14. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
    Oki K, Yamane K, Kamei N, Nojima H, Kohno N.
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association between visfatin levels and coronary artery disease in patients with chronic kidney disease.
    Lu YC, Hsu CC, Yu TH, Wang CP, Lu LF, Hung WC, Chiu CA, Chung FM, Lee YJ, Tsai IT.
    Iran J Kidney Dis; 2013 Nov; 7(6):446-52. PubMed ID: 24241090
    [Abstract] [Full Text] [Related]

  • 18. [Relations between fasting serum lipids and high-sensitivity C-reactive protein level in Chengdu residents].
    Shu Y, He S, Chen XP, Lü ZB, Yang R, Liu K, Cui KJ, Huang DJ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Feb; 40(2):125-30. PubMed ID: 22490712
    [Abstract] [Full Text] [Related]

  • 19. Serum visfatin levels and metabolic syndrome criteria in obese female subjects.
    de Luis DA, Aller R, Gonzalez Sagrado M, Conde R, Izaola O, de la Fuente B.
    Diabetes Metab Res Rev; 2013 Oct; 29(7):576-81. PubMed ID: 23704051
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.